These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12105273)

  • 1. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.
    De Francesco MA; Baronio M; Fiorentini S; Signorini C; Bonfanti C; Poiesi C; Popovic M; Grassi M; Garrafa E; Bozzo L; Lewis GK; Licenziati S; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9972-7. PubMed ID: 12105273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines.
    Vitale M; Caruso A; De Francesco MA; Rodella L; Bozzo L; Garrafa E; Grassi M; Gobbi G; Cacchioli A; Fiorentini S
    Br J Haematol; 2003 Jan; 120(2):337-43. PubMed ID: 12542496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of the HIV-1 matrix protein p17.
    Fiorentini S; Marini E; Caracciolo S; Caruso A
    New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens.
    Fiorentini S; Becker PD; Marini E; Marconi P; Avolio M; Tosti G; Link C; Manservigi R; Guzman CA; Caruso A
    Viral Immunol; 2006; 19(2):177-88. PubMed ID: 16817760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor.
    De Francesco MA; Caruso A; Fallacara F; Canaris AD; Dima F; Poiesi C; Licenziati S; Corulli M; Martinelli F; Fiorentini S; Turano A
    AIDS; 1998 Feb; 12(3):245-52. PubMed ID: 9517986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha.
    De Francesco MA; Poiesi C; Ricotta D; Manca N
    Virus Res; 2006 Jun; 118(1-2):170-7. PubMed ID: 16427155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines.
    Kinter AL; Poli G; Fox L; Hardy E; Fauci AS
    J Immunol; 1995 Mar; 154(5):2448-59. PubMed ID: 7868911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
    Tewari D; Goldstein SL; Notkins AL; Zhou P
    J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
    de Goede AL; Boers PH; Dekker LJ; Osterhaus AD; Gruters RA; Rimmelzwaan GF
    Vaccine; 2009 Sep; 27(42):5735-9. PubMed ID: 19647812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.
    Besançon F; Just J; Bourgeade MF; Van Weyenbergh J; Solomon D; Guillozo H; Wietzerbin J; Cayre YE
    J Interferon Cytokine Res; 1997 Aug; 17(8):461-7. PubMed ID: 9282826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
    Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
    Fiorentini S; Giagulli C; Caccuri F; Magiera AK; Caruso A
    Pharmacol Ther; 2010 Dec; 128(3):433-44. PubMed ID: 20816696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4(+) T cells.
    Poiesi C; De Francesco MA; Baronio M; Manca N
    Virus Res; 2008 Mar; 132(1-2):25-32. PubMed ID: 18036696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.